Navigation Links
SenesTech Scientists Attend International Workshop on Fertility in New Zealand
Date:3/4/2009

FLAGSTAFF, Ariz., March 4 /PRNewswire/ -- SenesTech, Inc. scientists, Drs. Loretta Mayer, Cheryl Dyer and Timothy Vail, were invited to attend the Third International Workshop on Fertility Control in Wildlife Management in Lincoln, New Zealand where they presented SenesTech's latest developments in humane animal population management. This invitation only meeting is organized by the governments of Australia, the United States, New Zealand and Great Britain, who are working together to support the development of new, more effective methods for wildlife management, and by treaty, will accept the research done in any one of the four countries. In previous years attendees have presented research on contraceptive vaccines, parasite-vectored fertility control, and oral bait delivery systems for fertility control. This invitation reflects the cutting edge nature of SenesTech's research into chemical fertility management in the rice field rat of Southeast Asia as it is the only non-governmental entity invited to the workshop during the four year history of this annual meeting.

SenesTech's initial product, ContraPest(TM), which is being developed to counteract the rice rat plague in the rice producing countries of the world, will dramatically improve rice yields in Southeast Asia by reducing the rice field rat population. Over half of the worlds 6 billion people depend on rice as their primary food source and Southeast Asia produces over 84% of this resource. Currently, 1/5-1/3 of the Southeast Asian rice crop is severely damaged by these rice field rats. SenesTech's product is a unique non-toxic, environmentally sound oral bait that can dramatically reduce this pest population, resulting in a substantial reduction in the devastation caused by rice field rats in just one growing season. A simple 10% increase in rice production as a result of population management through ContraPest(TM) will feed an additional 380 million people.

An additional SenesTech product, ChemSpay(TM) is the only product currently under development that has been shown to induce permanent sterility in female dogs. Further, SenesTech has a prototype drug delivery system that allows for a single exposure to induce sterility in dogs.

SenesTech is partnered with Dr. Lyn Hinds, the Senior Principal Research Scientist of the Commonwealth Scientific and Industrial Research Organisation (CSIRO) in Australia and Dr. Sudamaji at the Indonesian Centre for Rice Research (ICRR).

About: (SenesTech, Inc.) SenesTech is a platform technology company located in Flagstaff, Arizona, on the Northern Arizona Center for Emerging Technology campus. SenesTech specializes in humane animal population management products for companion animals and wildlife.


'/>"/>
SOURCE SenesTech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. SenesTech, Inc. Appoints Susan Airhart to Board of Directors
2. SenesTech, Inc. Commences Product Registration Process With Australian Government
3. SenesTech, Inc. Initiates Research Field Trials for ContraPest(R) in Indonesia
4. Arizona-Based SenesTech, Inc., Partners With Australia to Stop Starvation Due to Rice Shortages
5. Scientists prove graphenes edge structure affects electronic properties
6. Obama Advisor Joins Connecticut and International Scientists at New Haven Stem Cell Symposium
7. Scientists publish complete genetic blueprint of key biofuels crop
8. 2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields
9. BOXX Personal Supercomputer for Research Scientists Featured at SC08
10. NanoBio to Give Four Scientific Presentations at Upcoming National Meeting of Pharmaceutical Scientists
11. Scientists restore movement to paralyzed limbs through artificial brain-muscle connections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... , Feb. 12, 2016  PTC Therapeutics, Inc. ... annual STRIVE (Strategies to Realize Innovation, Vision and ... (DMD). STRIVE provides funds to patient advocacy organizations ... make meaningful contributions to the rare disease community ... of future patient advocates. Mary ...
(Date:2/11/2016)... NBIX ) today announced its financial results for the quarter ... --> For the fourth quarter of 2015, the ... per share, compared to a net loss of $19.4 million, or ... the year ended December 31, 2015, the Company reported a net ... to a net loss of $60.5 million, or $0.81 loss per ...
(Date:2/11/2016)... , Feb. 11, 2016  Bioethics International, a not-for-profit organization ... researched, developed, marketed and made accessible to patients around the ... had named the publication of the Good Pharma ... publication is also featured as one of BMJ Open ... last year that are most frequently read. Ed ...
(Date:2/11/2016)... (PRWEB) , ... February 11, ... ... business-to-business publication dedicated to delivering cutting-edge information focused on the development and ... Sciences to become a premier sponsor of the 2016 BioProcess International Awards ...
Breaking Biology Technology:
(Date:2/2/2016)... , Feb. 2, 2016 This ... the bioinformatic market by reviewing the recent advances ... tools that drive the field forward. Includes forecast ... Identify the challenges and opportunities that exist ... and software solution developers, as well as IT ...
(Date:2/2/2016)... MOUNTAIN VIEW, Calif. , Feb. 2, 2016 ... diabetic retinopathy market, Frost & Sullivan recognizes US-based ... North America Frost & Sullivan Award for New ... technology provider in North America ... standard in the rapidly growing diabetic retinopathy market. ...
(Date:1/28/2016)... -- Synaptics (NASDAQ: SYNA ), a leading developer of human ... December 31, 2015. --> --> ... 2 percent compared to the comparable quarter last year to $470.5 ... $35.0 million, or $0.93 per diluted share. ... quarter of fiscal 2016 grew 9 percent over the prior year ...
Breaking Biology News(10 mins):